Andrological diseases: varicocele, Peyronie disease, orchialgia, male infertility, and erectile dysfunction Urology short notes

Reading File
Reading File
Finding Sources
Searching PubMed

varicocele AND infertility

Searching PubMed

Peyronie disease

Searching PubMed

erectile dysfunction

Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Searching PubMed

orchialgia

Searching PubMed

male infertility

Searching the Web

EAU Guidelines 2026 male infertility sexual reproductive health Peyronie erectile dysfunction chronic scrotal pain varicocele

1. Varicocele

Definition: Abnormal dilatation and tortuosity of the pampiniform venous plexus due to reflux in the internal spermatic vein. It is more common on the left because the left testicular vein drains into the left renal vein at a right angle.
Clinical features
  • Often asymptomatic
  • Dull dragging scrotal discomfort, worse on standing/exertion
  • Infertility or abnormal semen parameters
  • “Bag of worms” above the testis on standing and Valsalva
  • Testicular hypotrophy, especially in adolescents
Grades
  • Grade I: palpable only on Valsalva
  • Grade II: palpable at rest
  • Grade III: visible through scrotal skin
  • Subclinical: demonstrable only on Doppler ultrasound
Evaluation
  • Examine standing and supine, with Valsalva.
  • Assess testicular volume and perform semen analysis if infertility is a concern.
  • Scrotal color Doppler: dilated veins with reflux.
  • A new right-sided, non-reducible, or persistent supine varicocele warrants evaluation for retroperitoneal pathology.
Indications for treatment
  • Persistent pain despite conservative measures
  • Infertile couple with a clinical varicocele, abnormal semen parameters, and potentially correctable female fertility
  • Adolescent with progressive testicular hypotrophy
Treatment
  • Observation, scrotal support, NSAIDs for minor symptoms
  • Microsurgical subinguinal varicocelectomy is commonly preferred due to lower recurrence/hydrocele risk.
  • Alternatives: inguinal or laparoscopic ligation, radiological embolization.
A recent meta-analysis reported improved assisted-reproduction outcomes after repair in selected infertile men, though patient selection remains important (2025 systematic review, PMID 40293106). See the current EAU male-infertility guideline.

2. Peyronie Disease

Definition: Acquired fibrotic plaque of the tunica albuginea causing penile curvature, shortening, indentation, pain, and sometimes erectile dysfunction.
Pathogenesis
  • Repetitive minor penile trauma during intercourse in a genetically susceptible man
  • Abnormal wound healing with collagen deposition and plaque formation
  • Associated with Dupuytren contracture and diabetes in some patients
Clinical stages
  1. Active or acute phase: penile pain, evolving curvature and plaque.
  2. Stable or chronic phase: pain usually resolves; curvature remains stable for at least 3-6 months.
Clinical features
  • Palpable firm plaque, commonly dorsolateral
  • Curvature during erection
  • Painful erection in active disease
  • Penile shortening, hourglass deformity
  • Difficulty with intercourse and psychological distress
Diagnosis
  • Mainly clinical: history, examination, measurement/documentation of erect curvature.
  • Penile duplex Doppler ultrasound may identify plaque/calcification and assess erectile hemodynamics, particularly before intervention.
Management
  • Counselling and partner involvement.
  • Observe if deformity is mild and intercourse remains satisfactory.
  • Active phase: analgesia, risk-factor control, selected traction therapy. Oral agents have limited supporting evidence.
  • Intralesional treatment may be considered for suitable stable curvature, depending on local availability and indication.
  • Surgery only after stable disease when intercourse is impaired:
    • Plication for adequate penile length and less severe curvature
    • Plaque incision/excision with grafting for severe curvature or complex deformity
    • Penile prosthesis, with modelling or straightening, if significant erectile dysfunction coexists.
Key point: The surgical aim is a functionally straight penis, not necessarily restoration of original length. Current EAU updates also note emerging conservative options, but evidence quality varies (EAU 2026 update).

3. Orchialgia / Chronic Scrotal Content Pain

Definition: Intermittent or constant pain localized to the testis, epididymis, or spermatic cord for at least 3 months, severe enough to interfere with daily activities.
Causes
  • Idiopathic
  • Epididymitis/orchitis, post-vasectomy pain syndrome
  • Varicocele, hydrocele, spermatocele
  • Trauma, prior inguinal or scrotal surgery
  • Testicular tumour
  • Referred pain: ureteric calculus, inguinal hernia, lumbar radiculopathy, hip disease
  • Pelvic-floor dysfunction and chronic pelvic pain syndrome
Red flags
  • Acute severe pain: exclude testicular torsion urgently.
  • Palpable mass or persistent unilateral pain: exclude testicular malignancy.
  • Fever, dysuria, urethral discharge: assess infection.
Evaluation
  • History: onset, trauma, surgery, urinary/sexual symptoms, radiation of pain.
  • Examine abdomen, inguinal canal, scrotal contents, prostate and pelvic floor when appropriate.
  • Urinalysis and culture if infection suspected.
  • Scrotal ultrasound with Doppler to exclude mass, torsion, varicocele, etc.
  • Consider CT if ureteric colic or referred retroperitoneal pathology is suspected.
Treatment
  1. Treat an identified cause.
  2. Conservative: reassurance, scrotal support, activity modification, NSAIDs.
  3. Neuropathic pain agents where indicated and pelvic-floor physiotherapy for pelvic-floor tenderness/dysfunction.
  4. Spermatic-cord block can be diagnostic and prognostic.
  5. Refractory, well-localized pain with response to cord block: microsurgical denervation of the spermatic cord may be considered.
  6. Epididymectomy or orchiectomy only in highly selected refractory cases. Orchiectomy is a last resort and may fail because pain can be neuropathic or referred.

4. Male Infertility

Definition: Failure to achieve pregnancy after 12 months of regular unprotected intercourse. A male factor contributes in about half of infertile couples.
Causes
  • Pre-testicular: hypogonadotropic hypogonadism, hyperprolactinaemia, systemic illness, exogenous testosterone/anabolic steroids.
  • Testicular: varicocele, cryptorchidism, mumps orchitis, torsion, chemotherapy/radiation, genetic disorders such as Klinefelter syndrome.
  • Post-testicular: obstruction of epididymis/vas/ejaculatory ducts, congenital bilateral absence of vas deferens, ejaculatory dysfunction.
  • Lifestyle/environmental: smoking, alcohol/drugs, obesity, heat exposure, toxins.
Initial assessment
  • Evaluate both partners simultaneously.
  • Reproductive/medical/sexual history and examination: testicular size, vas deferens, epididymis, varicocele, secondary sexual characteristics.
  • Semen analysis: at least two samples if the first is abnormal.
    • Semen defects: oligozoospermia, asthenozoospermia, teratozoospermia, azoospermia.
  • Hormones, especially FSH and morning testosterone, in azoospermia, oligozoospermia, small testes, or symptoms of endocrine disease.
  • Genetic testing in severe oligozoospermia or azoospermia, as indicated.
  • Scrotal ultrasound only when clinically indicated.
Management
  • Correct reversible causes: stop testosterone/anabolic steroids, manage systemic/endocrine disease, optimize weight and lifestyle.
  • Treat clinical varicocele in appropriately selected infertile men.
  • Obstructive azoospermia: reconstructive surgery or surgical sperm retrieval.
  • Hypogonadotropic hypogonadism: gonadotropin therapy to induce spermatogenesis.
  • Assisted reproduction:
    • IUI for selected mild defects
    • IVF or ICSI for severe sperm abnormalities or failed conventional therapy
    • Surgical sperm retrieval with ICSI in azoospermia
Important: Testosterone replacement suppresses spermatogenesis and should not be used in a man actively trying to conceive. The EAU guideline defines infertility and outlines the recommended couple-based evaluation.

5. Erectile Dysfunction (ED)

Definition: Persistent inability to attain and/or maintain a penile erection sufficient for satisfactory sexual performance.
Causes
  • Vasculogenic: hypertension, diabetes, dyslipidaemia, smoking, atherosclerotic cardiovascular disease
  • Neurogenic: spinal cord injury, multiple sclerosis, diabetic neuropathy, pelvic surgery
  • Endocrine: hypogonadism, hyperprolactinaemia, thyroid disease
  • Psychogenic: anxiety, depression, relationship difficulty
  • Drug-induced: some antihypertensives, antidepressants, antipsychotics, opioids
  • Structural: Peyronie disease
Why it matters: ED may be an early marker of cardiovascular disease. Evaluate cardiovascular risk factors rather than treating it as an isolated symptom.
Assessment
  • Sexual, medical, medication, psychosocial, and cardiovascular history.
  • Focused examination: blood pressure, BMI/waist, peripheral pulses, genital and neurological examination.
  • Investigations: fasting glucose/HbA1c, lipid profile, and morning total testosterone. Other hormone tests when clinically indicated.
  • Use a validated questionnaire, such as IIEF-5, to grade severity.
Management
  1. Lifestyle and risk-factor modification: exercise, weight reduction, smoking cessation, glycaemic/BP/lipid control; manage depression and relationship factors.
  2. PDE5 inhibitors are first-line therapy: sildenafil, tadalafil, vardenafil, avanafil.
    • Require sexual stimulation.
    • Contraindicated with nitrates because of potentially profound hypotension.
  3. Address testosterone deficiency if confirmed and clinically relevant. Testosterone alone is not a general ED treatment.
  4. Second-line options:
    • Vacuum erection device
    • Intraurethral alprostadil
    • Intracavernosal injection therapy, such as alprostadil
  5. Penile prosthesis for severe refractory ED or when other treatments are unsuitable.
Counselling: Explain correct PDE5 inhibitor use, including adequate dose, timing, repeated trials, avoidance of heavy meals with sildenafil, and sexual stimulation. Many apparent “non-responders” have used the medication incorrectly.
Exam summary: ED is frequently multifactorial. Treat modifiable risk factors and the underlying cause, then use PDE5 inhibitors first line unless contraindicated.
Recent evidence continues to reinforce the strong relationship between obesity and ED (systematic review, PMID 41337750).
This is a shared conversation. Sign in to Orris to start your own chat.